Literature DB >> 24034666

Allopurinol on hypertension: insufficient evidence to recommend.

Pedro H F Gois1, Weverton M Luchi, Antonio C Seguro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24034666      PMCID： PMC8033869          DOI： 10.1111/jch.12154

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  6 in total

1.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

Authors:  Yui-Pong Siu; Kay-Tai Leung; Matthew Ka-Hang Tong; Tze-Hoi Kwan
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

2.  A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function.

Authors:  Mehmet Kanbay; Bulent Huddam; Alper Azak; Yalcin Solak; Gulay Kocak Kadioglu; Ismail Kirbas; Murat Duranay; Adrian Covic; Richard J Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

Review 3.  Pharmacotherapy for hyperuricemia in hypertensive patients.

Authors:  Pedro Henrique França Gois; Edison Regio de Moraes Souza
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

4.  Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.

Authors:  Mehmet Kanbay; Adem Ozkara; Yusuf Selcoki; Bunyamin Isik; Faruk Turgut; Nuket Bavbek; Ebru Uz; Ali Akcay; Ramazan Yigitoglu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2007-08-15       Impact factor: 2.370

5.  Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Authors:  Daniel I Feig; Beth Soletsky; Richard J Johnson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

Review 6.  Effect of allopurinol on blood pressure: a systematic review and meta-analysis.

Authors:  Vikram Agarwal; Nidhi Hans; Franz H Messerli
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-20       Impact factor: 3.738
  6 in total
  2 in total

Review 1.  Hyperuricemia, gout, and cardiovascular disease: an update.

Authors:  Aryeh M Abeles
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

2.  Pharmacotherapy for hyperuricaemia in hypertensive patients.

Authors:  Pedro Henrique França Gois; Edison Regio de Moraes Souza
Journal:  Cochrane Database Syst Rev       Date:  2020-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.